KABUKI SYNDROME 2; KABUK2

Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary

Literature (3)

Literature for OMIM 300867: KABUKI SYNDROME 2; KABUK2

Xenbase Articles:
(

Denotes literature images)

The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration., Schwenty-Lara J,Nehl D,Borchers A, Hum Mol Genet. January 15, 2020; 29(2):1460-2083.
Role of epigenetics and miRNAs in orofacial clefts., Garland MA,Sun B,Zhang S,Reynolds K,Ji Y,Zhou CJ, Birth Defects Res. November 1, 2020; 112(19):2472-1727.
Using Xenopus to analyze neurocristopathies like Kabuki syndrome., Schwenty-Lara J,Pauli S,Borchers A, Genesis. February 1, 2021; 59(1-2):1526-968X.

The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration., Schwenty-Lara J,Nehl D,Borchers A, Hum Mol Genet. January 15, 2020; 29(2):1460-2083.

Role of epigenetics and miRNAs in orofacial clefts., Garland MA,Sun B,Zhang S,Reynolds K,Ji Y,Zhou CJ, Birth Defects Res. November 1, 2020; 112(19):2472-1727.

Using Xenopus to analyze neurocristopathies like Kabuki syndrome., Schwenty-Lara J,Pauli S,Borchers A, Genesis. February 1, 2021; 59(1-2):1526-968X.